Wednesday, June 10, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 82 of 200 Β· By data quality, then INN

  1. lutetium lu-177 vipivotide tetraxetan

    PLUVICTO

    INTRAVENOUS FDA: approved

  2. lypressin

    DIAPID

    NASAL FDA: approved

  3. macimorelin acetate

    MACRILEN

    ORAL FDA: approved

  4. macitentan

    OPSUMIT Janssen-Cilag Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    C02KX54
  5. mafenide acetate

    MAFENIDE ACETATE

    TOPICAL FDA: approved

  6. magnesium acetate tetrahydrate

    PLASMA-LYTE 56 IN PLASTIC CONTAINER

    INJECTION FDA: approved

  7. magnesium chloride

    PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER

    IRRIGATION FDA: approved

  8. magnesium hydroxide

    MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE

    ORAL FDA: approved

  9. magnesium sulfate anhydrous

    MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE

    ORAL FDA: approved

  10. malathion

    MALATHION

    TOPICAL FDA: approved

  11. mangafodipir trisodium

    TESLASCAN

    INJECTION FDA: approved

  12. manganese chloride

    MANGANESE CHLORIDE IN PLASTIC CONTAINER

    INJECTION FDA: approved

  13. manganese chloride tetrahydrate

    LUMENHANCE

    ORAL FDA: approved

  14. manganese sulfate

    MANGANESE SULFATE

    INJECTION FDA: approved

  15. maraviroc

    CELSENTRI ViiV Healthcare Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    J05AX09
  16. margetuximab-cmkb

    MARGENZA

    INJECTION FDA: approved

  17. marstacimab-hncq

    HYMPAVZI

    SUBCUTANEOUS FDA: approved

  18. masoprocol

    ACTINEX

    TOPICAL FDA: approved

  19. mavacamten

    CAMZYOS Bristol-Myers Squibb Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    C01EB
  20. mavorixafor

    XOLREMDI

    ORAL FDA: approved Β· EMA: approved

    L03AX24
  21. mazindol

    SANOREX

    ORAL FDA: approved

  22. mebendazole

    PHARMACY ACTION WORM TREATMENT Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· TGA: approved

  23. mebutamate

    DORMATE

    ORAL FDA: approved

  24. mecamylamine hydrochloride

    INVERSINE

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.